ZA201109381B - Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoforms - Google Patents
Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoformsInfo
- Publication number
- ZA201109381B ZA201109381B ZA2011/09381A ZA201109381A ZA201109381B ZA 201109381 B ZA201109381 B ZA 201109381B ZA 2011/09381 A ZA2011/09381 A ZA 2011/09381A ZA 201109381 A ZA201109381 A ZA 201109381A ZA 201109381 B ZA201109381 B ZA 201109381B
- Authority
- ZA
- South Africa
- Prior art keywords
- predicting
- risk
- diagnostic method
- cancer recurrence
- recurrence based
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 102000001708 Protein Isoforms Human genes 0.000 title 1
- 108010029485 Protein Isoforms Proteins 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 108010034959 macroH2A histone Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09008679A EP2270510A1 (en) | 2009-07-02 | 2009-07-02 | Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms |
| PCT/EP2010/004008 WO2011000573A1 (en) | 2009-07-02 | 2010-07-02 | Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoforms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201109381B true ZA201109381B (en) | 2012-08-29 |
Family
ID=41100520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2011/09381A ZA201109381B (en) | 2009-07-02 | 2011-12-20 | Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoforms |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20120171225A1 (enExample) |
| EP (2) | EP2270510A1 (enExample) |
| JP (1) | JP5792165B2 (enExample) |
| CN (1) | CN102472753B (enExample) |
| AU (1) | AU2010268389B2 (enExample) |
| BR (1) | BRPI1011925A2 (enExample) |
| CA (1) | CA2766656A1 (enExample) |
| ES (1) | ES2681687T3 (enExample) |
| SG (1) | SG177398A1 (enExample) |
| WO (1) | WO2011000573A1 (enExample) |
| ZA (1) | ZA201109381B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201115098D0 (en) * | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| GB201604806D0 (en) * | 2016-03-22 | 2016-05-04 | Singapore Volition Pte Ltd | Method of identifying a cancer of unknown origin |
| EP3508855A1 (en) * | 2018-01-05 | 2019-07-10 | Allianz Pharmascience Ltd | Method for the selection of patients and kit |
| EP3546944A1 (en) * | 2018-03-30 | 2019-10-02 | Universite d'Aix-Marseille (AMU) | Diagnosis and treatment of a cancer based on the overexpression of the adamtsl5 gene |
| CN108957004B (zh) * | 2018-07-09 | 2021-10-19 | 东南大学 | 检测H3K9me2和H3K36me3表达量的试剂在制备胃癌预后评估试剂盒中的应用 |
| CN111896740B (zh) * | 2019-05-06 | 2025-02-11 | 山东大学 | 诊断或预测生育缺陷的试剂盒 |
| CN119736252B (zh) * | 2025-01-15 | 2025-06-27 | 首都医科大学 | 组蛋白变体macroH2A调控巨噬细胞功能在改善肿瘤免疫微环境中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2197915B (en) | 1986-11-19 | 1990-11-14 | Rolls Royce Plc | Improvements in or relating to fluid bearings |
| EP1388734B1 (en) * | 2002-08-01 | 2004-03-03 | MTM Laboratories AG | Method for solution based diagnosis |
| US20020052308A1 (en) * | 1999-03-12 | 2002-05-02 | Rosen Craig A. | Nucleic acids, proteins and antibodies |
| US20030190640A1 (en) * | 2001-05-31 | 2003-10-09 | Mary Faris | Genes expressed in prostate cancer |
| US20030124579A1 (en) * | 2001-09-05 | 2003-07-03 | Eos Biotechnology, Inc. | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer |
| US20050085628A1 (en) * | 2002-01-31 | 2005-04-21 | Kinya Yoda | Production of hybridoma producing antihuman cenp-a peptide monoclonal antibody and method of using the same |
| CN100480382C (zh) * | 2002-08-16 | 2009-04-22 | 抗癌公司 | 实时测量细胞反应 |
| US20050181375A1 (en) * | 2003-01-10 | 2005-08-18 | Natasha Aziz | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of metastatic cancer |
| WO2004106511A1 (ja) * | 2003-05-30 | 2004-12-09 | Nippon Shinyaku Co., Ltd. | Ｂｃｌ−２の発現抑制をするオリゴ二本鎖ＲＮＡとそれを含有する医薬組成物 |
| EP1682904A2 (en) * | 2003-11-04 | 2006-07-26 | Roche Diagnostics GmbH | Method for distinguishing who classified aml subtypes |
| DE102004037860A1 (de) * | 2004-08-04 | 2006-03-16 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen |
| WO2006119435A2 (en) * | 2005-05-04 | 2006-11-09 | Invitrogen Corporation | Identification of cancer biomarkers and phosphorylated proteins |
| CA2612021A1 (en) * | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions and methods for treating and diagnosing cancer |
| US9150628B2 (en) * | 2005-11-14 | 2015-10-06 | Centre National De La Recherche Scientifique (Cnrs) | PARP inhibitors |
| WO2008144345A2 (en) * | 2007-05-17 | 2008-11-27 | Bristol-Myers Squibb Company | Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators |
| JP2008292424A (ja) * | 2007-05-28 | 2008-12-04 | Nippon Medical School | 腫瘍の検出方法 |
| BRPI0815460A2 (pt) * | 2007-09-07 | 2019-02-26 | Univ Bruxelles | kit de diagnóstico ou dispositivo e método para prognóstico de cancro em sujeitos mamíferos |
| CA2726531A1 (en) * | 2008-06-05 | 2009-12-10 | University Health Network | Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
-
2009
- 2009-07-02 EP EP09008679A patent/EP2270510A1/en not_active Withdrawn
-
2010
- 2010-07-02 SG SG2011096849A patent/SG177398A1/en unknown
- 2010-07-02 AU AU2010268389A patent/AU2010268389B2/en not_active Ceased
- 2010-07-02 EP EP10730098.0A patent/EP2449383B1/en not_active Not-in-force
- 2010-07-02 CN CN201080029880.5A patent/CN102472753B/zh not_active Expired - Fee Related
- 2010-07-02 US US13/380,324 patent/US20120171225A1/en not_active Abandoned
- 2010-07-02 WO PCT/EP2010/004008 patent/WO2011000573A1/en not_active Ceased
- 2010-07-02 BR BRPI1011925A patent/BRPI1011925A2/pt not_active Application Discontinuation
- 2010-07-02 CA CA2766656A patent/CA2766656A1/en not_active Abandoned
- 2010-07-02 JP JP2012518798A patent/JP5792165B2/ja not_active Expired - Fee Related
- 2010-07-02 ES ES10730098.0T patent/ES2681687T3/es active Active
-
2011
- 2011-12-20 ZA ZA2011/09381A patent/ZA201109381B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012531612A (ja) | 2012-12-10 |
| US20120171225A1 (en) | 2012-07-05 |
| EP2449383B1 (en) | 2018-05-16 |
| AU2010268389A1 (en) | 2012-01-19 |
| BRPI1011925A2 (pt) | 2017-10-10 |
| EP2270510A1 (en) | 2011-01-05 |
| AU2010268389A2 (en) | 2012-01-12 |
| WO2011000573A1 (en) | 2011-01-06 |
| SG177398A1 (en) | 2012-02-28 |
| EP2449383A1 (en) | 2012-05-09 |
| AU2010268389B2 (en) | 2014-09-11 |
| CA2766656A1 (en) | 2011-01-06 |
| ES2681687T3 (es) | 2018-09-14 |
| CN102472753B (zh) | 2015-02-11 |
| JP5792165B2 (ja) | 2015-10-07 |
| CN102472753A (zh) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2643698T3 (pl) | Biomarkery do przewidywania skuteczności immunoterapii raka | |
| WO2011008262A9 (en) | Methods and apparatus for diagnosis and/or prognosis of cancer | |
| GB201312007D0 (en) | X-Ray tomographic inspection systems for the identifaction of specific target lines | |
| PL2653546T3 (pl) | Marker do ustalenia rokowania raka żołądka i sposób ustalenia rokowania raka żołądka | |
| ZA201207229B (en) | Method for breast cancer recurrence prediction under endocrine treatment | |
| PL2482849T3 (pl) | Skojarzona immunoterapia w leczeniu nowotworu | |
| EP2436013A4 (en) | X-ray tomographic inspection system for the idendification of specific target items | |
| GB0906458D0 (en) | Macromolecules for diagnosis and prognosis | |
| AP2011005956A0 (en) | Methods of treatment for solid tumors. | |
| ZA201109381B (en) | Diagnostic method for predicting the risk of cancer recurrence based on histone macroh2a isoforms | |
| WO2012012225A9 (en) | Predicting cancer outcome | |
| PT2207037T (pt) | Método para a deteção de cancro | |
| GB201012590D0 (en) | Methods for diagnosing cancer | |
| ZA201703026B (en) | Biomarkers for the prediction of incident cancer | |
| IL253615A0 (en) | Phosphorylated hsp90alpha polypeptide from plasma, antibodies against it and their uses in cancer diagnosis | |
| GB2494580B (en) | Method for diagnosing lung cancer | |
| ZA201303258B (en) | Method of assaying noble metals | |
| SG11201402115TA (en) | Methods for diagnosis and/or prognosis of gynecological cancer | |
| PL2444811T3 (pl) | Sposoby diagnozowania lub prognozowania raka jelita grubego | |
| ZA201200110B (en) | Biomarker for selecting patients and related methods | |
| EP2490038A4 (en) | SYSTEM AND METHOD FOR TRACKING THE LOCATION OF A BUILDING EQUIPMENT | |
| GB201004304D0 (en) | Biomarkers for prostate cancer | |
| AP2011005893A0 (en) | Thia-triaza-cyclopentazulenes as P13-kinases inhibitors for the treatment of cancer. | |
| GB201115191D0 (en) | Apparatus for the utilisation of thermal radiation | |
| TWM370152U (en) | Loading apparatus for hard disk |